GAM
EXAS

Grandview Asset Management’s Exact Sciences EXAS Stock Holding History

Grandview Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,748
Closed -$869K – 92
2019
Q3 		$869K Buy
9,748
+7,850
+414% +$894K 0.79% 34
2019
Q2 		$224K Buy
+1,898
New +$191K 0.21% 96

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Grandview Asset Management's EXAS Position: Q4 2019 in Review

Grandview Asset Management sold out of Exact Sciences (EXAS) in Q4 2019, closing a stake of 9,748 shares — an estimated $869K sold.

Grandview Asset Management first reported a position in EXAS in Q2 2019 and held it in 2 quarters. The position peaked at $869K in Q3 2019. 526 funds tracked by Wall St. Rank hold EXAS as of Q4 2019.

  • Grandview Asset Management reported no remaining Exact Sciences position as of Q4 2019 after selling out during the quarter.
  • Grandview Asset Management sold 9,748 Exact Sciences shares in Q4 2019, an estimated $869K.
  • Grandview Asset Management first reported a position in Exact Sciences in Q2 2019 and held it in 2 quarters.
  • Grandview Asset Management's Exact Sciences position peaked at $869K in Q3 2019.
  • 526 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2019.

Based on Grandview Asset Management's 13F filing for Q4 2019, filed 28 Jan 2020.